News
Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...
GLP-1 RAs used by adults with type 2 diabetes and obesity is linked to lower risk for dementia, stroke, and mortality vs ...
The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These ...
Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...
Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...
Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how real-world ...
A recent study discovered that individuals using GLP-1 medications may develop severe acid reflux.Researchers discovered that ...
16h
HealthDay on MSNGLP-1 Medications May Increase the Risk of Severe Acid RefluxNationwide shutdown called as tensions rise over police allegations Should Audi, Mercedes, and BMW Be Worried? Nio ET9 Luxury ...
In older patients with cancer and type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with ...
11h
Parade on MSNRHONJ's Dolores Catania Opens Up About Her GLP-1All About Sarah Jessica Parker’s Son James and Twins Tabitha and Marion (Who Didn’t Know She Was Famous) Leavitt Gets ...
A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists ...
Longer treatment duration, using semaglutide, higher percentage body fat, and nondiabetic status may be associated with better weight reduction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results